| Size | Price | Stock |
|---|---|---|
| 100 mg | Get quote | |
| 250 mg | Get quote | |
| 500 mg | Get quote | |
| We match the lowest price on market. | ||
We offer a substantial discount on larger orders, please inquire via [email protected]
or Fax: (86)21-58955996
Inquiry for price and availability only. Please place your order via our email or fax.
| Cat. No. : | HY-122739 |
| M.Wt: | 388.49 |
| Formula: | C23H20N2O2S |
| Purity: | >98 % |
| Solubility: |
Rac1-IN-2 is a small-molecule Rac1 inhibitor. Rac1-IN-2 inhibits Rac1-mediated signaling by blocking the binding of active Rac1 to PAK1 (IC50 = 88 nM), exhibits selectivity for Rac1 over Cdc42 and RhoA, and suppresses the proliferation, migration, clonogenicity, and viability of pancreatic cancer cells. Rac1-IN-2 can be used for research on pancreatic cancer[1].
In Vitro:Rac1-IN-2 (compound #6) (0.001-100 μM; 1 h) disrupts Rac1-PAK1 complex formation with an IC50 of 88 nM[1].
Rac1-IN-2 (10 μM; 2 h) inhibits Rac1 activity in CD18/HPAF cells[1].
Rac1-IN-2 (1-50 μM; 2 h) inhibits EGF-induced Rac1 activation in CD18/HPAF cells with an EC50 of 22.4 μM[1].
Rac1-IN-2 (50 μM; 2 h) selectively inhibits Rac1 activity in CD18/HPAF cells without inhibiting Cdc42 or RhoA[1].
Rac1-IN-2 (25 μM; 24-120 h) inhibits the proliferation of Capan1 and CD18/HPAF cells[1].
Rac1-IN-2 (50 μM; 24-48 h) inhibits the migration of Capan1 and CD18/HPAF cells, with maximal wound closure inhibition of approximately 60% and 40%, respectively[1].
Rac1-IN-2 (50 μM; 1 h pre-incubation; 24 h migration) inhibits transwell migration of Capan1 and CD18/HPAF cells[1].
Rac1-IN-2 (7 days) reduces clonogenic survival of Capan1 cells, with little effect on HPNE normal pancreatic ductal cells[1].
Rac1-IN-2 (1.6-100 μM; 7 days) reduces the viability of AsPC-1, Capan1, and CD18/HPAF cells with EC50 values of 14.7, 24.2, and 23.5 μM, respectively[1].
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Autem earum hic iste maiores, nam neque rem suscipit. Adipisci consequatur error exercitationem fugit ipsam optio qui, quibusdam repellendus sed vero! Debitis.
Inquiry Information
Your information is safe with us.